{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:35:59Z","timestamp":1771630559681,"version":"3.50.1"},"reference-count":26,"publisher":"BMJ","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"published-print":{"date-parts":[[1975,4,1]]},"DOI":"10.1136\/jnnp.38.4.331","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T21:02:42Z","timestamp":1226350962000},"page":"331-335","source":"Crossref","is-referenced-by-count":54,"title":["Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias."],"prefix":"10.1136","volume":"38","author":[{"given":"D","family":"Tarsy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J D","family":"Parkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C D","family":"Marsden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-2999(70)90006-3","article-title":"Receptor activity and turnover of dopamine and noradrenaline after neuroleptics","volume":"11","author":"Anden, N.-E.; Butcher, S.G.; Corrodi, H.; Fuxe, K.; Ungerstedt, U.","year":"1970","unstructured":"Anden, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K., and Ungerstedt, U. (1970). Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. European Journal of Pharmacology, 11, 303-314.","journal-title":"European Journal of Pharmacology"},{"key":"ref_2","first-page":"975","article-title":"Effets cliniques et electroencephalographiques du metoclopramide en psychiatrie","volume":"20","author":"Borenstein, P.; Bles, G.","year":"1965","unstructured":"Borenstein, P., and Bles, G. (1965). Effets cliniques et electroencephalographiques du metoclopramide en psychiatrie. Therapie, 20, 975-995.","journal-title":"Therapie"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/bmj.4.5890.491-b","article-title":"Pyridoxine and Parkinsonism","volume":"4","author":"Carter, S.M.","year":"1973","unstructured":"Carter, S. M. (1973). Pyridoxine and Parkinsonism. British Medical Journal, 4, 491.","journal-title":"British Medical Journal"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/adc.45.239.130","article-title":"Dystonic reactions in children caused by metoclopramide","volume":"45","author":"Casteels-Van Daele, M.; Jaeken, J.; Schueren, P.van der; Zimmerman, A.; Bon, P.van den","year":"1970","unstructured":"Casteels-Van Daele, M., Jaeken, J., Schueren, P. van der, Zimmerman, A., and Bon, P. van den (1970). Dystonic reactions in children caused by metoclopramide. Archives of Disease in Childhood, 45, 130-133.","journal-title":"Archives of Disease in Childhood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00428687","article-title":"Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect?","volume":"32","author":"Costall, B.; Naylor, R.J.","year":"1973","unstructured":"Costall, B., and Naylor, R. J. (1973). Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect? Psychopharmacologia (Berl.), 32, 161-170.","journal-title":"Psychopharmacologia (Berl.)"},{"key":"ref_6","first-page":"316","article-title":"Acute drug-induced extrapyramidal syndromes","volume":"211","author":"De Silva, K.L.; Muller, P.J.; Pearce, J.","year":"1973","unstructured":"De Silva, K. L., Muller, P. J., and Pearce, J. (1973). Acute drug-induced extrapyramidal syndromes. Practitioner (Lond.), 211. 316-320.","journal-title":"Practitioner (Lond.)"},{"key":"ref_7","article-title":"Pharmacological evidence for cerebral dopamine receptor blockade by metoclopramide in rodents","author":"Dolphin, A.; Jenner, P.; Marsden, C.D.; Pycock, C.; Tarsy, D.","year":"1975","unstructured":"Dolphin, A., Jenner, P., Marsden, C. D., Pycock, C., and Tarsy, D. (1975). Pharmacological evidence for cerebral dopamine receptor blockade by metoclopramide in rodents. Psychopharmacologia (Berl.). (In press.)"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/BF01943894","article-title":"Inhibition of the apomorphine gnawing compulsion by amantadine","volume":"29","author":"Hackman, R.; Pentikainen, P.; Neuvonen, P.J.; Vapaatalo, H.","year":"1973","unstructured":"Hackman, R., Pentikainen, P., Neuvonen, P. J., and Vapaatalo, H. (1973). Inhibition of the apomorphine gnawing compulsion by amantadine. Experientia, 29, 1524-1525.","journal-title":"Experientia"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0140-6736(73)91124-0","article-title":"Pyridoxine in parkinsonism","volume":"2","author":"Hildick-Smith, M.","year":"1973","unstructured":"Hildick-Smith, M. (1973). Pyridoxine in parkinsonism. Lancet, 2, 1029-1030.","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/oxfordjournals.bmb.a070990","article-title":"Dopamine in the basal ganglia","volume":"29","author":"Hornykiewicz, 0","year":"1973","unstructured":"Hornykiewicz, 0. (1973). Dopamine in the basal ganglia. British Medical Bulletin, 29, 172-178.","journal-title":"British Medical Bulletin"},{"key":"ref_11","first-page":"676","article-title":"Gastrointestinal actions of metoclopramide. Gastroenterolog'","volume":"52","author":"Jacoby, H.I.; Brodie, D.A.","year":"1967","unstructured":"Jacoby, H. I., and Brodie, D. A. (1967). Gastrointestinal actions of metoclopramide. Gastroenterolog', 52, 676-684."},{"key":"ref_12","first-page":"841856","article-title":"Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? Part 4","volume":"17","author":"Janssen, P.A.J.; Niemegeers, C.J.E.; Schellekens, K.H.L.; Lenaerts, F.M.","year":"1967","unstructured":"Janssen, P. A. J., Niemegeers, C. J. E., Schellekens, K. H. L., and Lenaerts, F. M. (1967). Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? Part 4. Arzneimittel-Forschung, 17, 841856.","journal-title":"Arzneimittel-Forschung"},{"key":"ref_13","first-page":"723","article-title":"Action antiemetique du metoclopramide vis-a-vis de l'apomorphine et de l'hydergine. Comptes Rendus des Seances de la Societe de Biologie et de ses","volume":"158","author":"Justin-Besancon, L.; Laville, C.","year":"1964","unstructured":"Justin-Besancon, L., and Laville, C. (1964). Action antiemetique du metoclopramide vis-a-vis de l'apomorphine et de l'hydergine. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, 158, 723-727.","journal-title":"Filiales"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/jnnp.37.4.427","article-title":"Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias","volume":"37","author":"Klawans, Jr, H.L.; Weiner, W.J.","year":"1974","unstructured":"Klawans, H. L., Jr, and Weiner, W. J. (1974). Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias. Journal of Neurology, Neurosurgery, and Psychiatry, 37, 427-430.","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"ref_15","first-page":"577","article-title":"Protection exercee par le metoclopramide contre les effets vomitifs du sulfate de cuivre","volume":"12","author":"Laville, C.","year":"1964","unstructured":"Laville, C. (1964). Protection exercee par le metoclopramide contre les effets vomitifs du sulfate de cuivre. PathologieBiologie (Paris), 12, 577-578.","journal-title":"PathologieBiologie (Paris)"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/bmj.2.5921.729","article-title":"Metaclopramide and prolactin","volume":"2","author":"McNeilly, A.S.; Thorner, M.O.; Volans, G.; Besser, G.M.","year":"1974","unstructured":"McNeilly, A. S., Thorner, M. O., Volans, G., and Besser, G. M. (1974). Metaclopramide and prolactin. British Medical Journal, 2, 729.","journal-title":"British Medical Journal"},{"key":"ref_17","first-page":"964","article-title":"Technique pour l'etude de l'action centrale de poisons emetiques et anti-emetiques. Comptes Rendus des Seances de la Societe, de Biologie et de ses","volume":"158","author":"Malmejac, J.; Laville, C.; Margarit, J.","year":"1964","unstructured":"Malmejac, J., Laville, C., and Margarit, J. (1964). Technique pour l'etude de l'action centrale de poisons emetiques et anti-emetiques. Comptes Rendus des Seances de la Societe, de Biologie et de ses Filiales, 158, 964-965.","journal-title":"Filiales"},{"key":"ref_18","first-page":"1459","article-title":"A year's comparison of treatment of patients","volume":"2","author":"Marsden, C.D.; Parkes, J.D.; Rees, J.E.","year":"1973","unstructured":"Marsden, C. D., Parkes, J. D., and Rees, J. E. (1973). A year's comparison of treatment of patients with Parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa alone. Lancet, 2, 1459-1462."},{"key":"ref_19","first-page":"200","article-title":"Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?","volume":"32","author":"Matthysse, S.","year":"1973","unstructured":"Matthysse, S. (1973). Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? Federation Proceedings, 32, 200-205.","journal-title":"Federation Proceedings"},{"key":"ref_20","first-page":"345","article-title":"Locus of emetic action of epinephrine and dopa in dogs","volume":"139","author":"Peng, M.T.","year":"1963","unstructured":"Peng, M. T. (1963). Locus of emetic action of epinephrine and dopa in dogs. Journal of Pharmacology and Experimental Therapeutics, 139, 345-349.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"ref_21","first-page":"9","article-title":"Metoclopramide-a new pharmacological approach?","volume":"49","author":"Robinson, 0. P. W","year":"1973","unstructured":"Robinson, 0. P. W. (1973a). Metoclopramide-a new pharmacological approach? Postgraduate Medical Jouirnal, 49, Suppl. 4, 9-12.","journal-title":"Postgraduate Medical Jouirnal"},{"issue":"4","key":"ref_22","first-page":"77","article-title":"Metoclopramide-side effects and safety","volume":"49","author":"Robinson, 0. P. W","year":"1973","unstructured":"Robinson, 0. P. W. (1973b). Metoclopramide-side effects and safety. Postgradtate Medical Journal, 49, Suppl. 4, 77-80.","journal-title":"Postgradtate Medical Journal"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJM197408222910822","article-title":"Dyskinesia after fenfluramine","volume":"291","author":"Sananman, M.L.","year":"1974","unstructured":"Sananman, M. L. (1974). Dyskinesia after fenfluramine. New England Journal of Medicine, 291, 422.","journal-title":"New England Journal of Medicine"},{"key":"ref_24","first-page":"850851","article-title":"Fenfluramine and dyskinesias","volume":"291","author":"Shoulson, I.; Chase, T.N.","year":"1974","unstructured":"Shoulson, I., and Chase, T. N. (1974). Fenfluramine and dyskinesias. New England Journal of Medicine, 291, 850851.","journal-title":"New England Journal of Medicine"},{"key":"ref_25","first-page":"75","article-title":"NVonparametric Statistics for the Behavioral Sciences","author":"Siegel, S.","year":"1956","unstructured":"Siegel, S. (1956). NVonparametric Statistics for the Behavioral Sciences, p. 75-83. McGraw-Hill: New York."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archinte.1972.03650030031008","article-title":"Prolactin secretion in patients treated with various drugs","volume":"130","author":"Turkington, R.W.","year":"1972","unstructured":"Turkington, R. W. (1972). Prolactin secretion in patients treated with various drugs. Archives of Internal Medicine, 130, 349-354.","journal-title":"Archives of Internal Medicine"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp.38.4.331","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T02:32:18Z","timestamp":1601087538000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp.38.4.331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1975,4,1]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1975,4,1]]}},"URL":"https:\/\/doi.org\/10.1136\/jnnp.38.4.331","relation":{},"ISSN":["0022-3050"],"issn-type":[{"value":"0022-3050","type":"print"}],"subject":[],"published":{"date-parts":[[1975,4,1]]}}}